Clincosm LogoSign in Get a demo

fsgs

Showing 1 - 11 of 11
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

NEPTUNE Match Study

Enrolling by invitation
  • Nephrotic Syndrome in Children
  • +7 more
  • Communication
  • Atlanta, Georgia
  • +15 more
Jan 30, 2023

Focal Segmental Glomerulosclerosis and Minimal Change Disease

Not yet recruiting
  • Focal Segmental Glomerulosclerosis
  • +3 more
  • Biospecimen collection
  • Data collection
  • Ann Arbor, Michigan
    University of Michigan
Dec 6, 2022

Bortezomib, Glomerulonephritis, MN Trial in Shanghai (Bortezomib)

Recruiting
  • Bortezomib
  • +5 more
  • Shanghai, Shanghai, China
    Ruijin Hospital, Shanghai Jiao Tong University School of Medicin
Oct 28, 2022

Adult and Child Patients and Parents of Swelling Due to

Recruiting
  • Fluid Overload
  • +12 more
  • Interview
  • Ann Arbor, Michigan
    University of Michigan
Aug 16, 2022

FSGS, MCD, Focal Segmental Glomerulosclerosis Trial in United States (adalimumab)

Recruiting
  • FSGS
  • +3 more
  • Ann Arbor, Michigan
  • +3 more
Jan 31, 2022

FSGS, Renal Transplantation, Kidney Transplantation Trial in Chapel Hill (Acthar)

Withdrawn
  • FSGS
  • +2 more
  • Chapel Hill, North Carolina
    University of North Carolina at Chapel Hill
Aug 26, 2021

FSGS, Focal Segmental Glomerulosclerosis, Glomerulosclerosis Trial in Worldwide (Placebo, CCX140-B)

Completed
  • FSGS
  • +2 more
  • Phoenix, Arizona
  • +37 more
Apr 2, 2021

FSGS Trial in Washington (Acthar)

Recruiting
  • FSGS
  • Washington, District of Columbia
    Medstar Georgetown Transplant Institute
Dec 10, 2020

FSGS, Proteinuria Trial in Miami (Rituximab)

Terminated
Has Results
  • FSGS
  • Proteinuria
  • Miami, Florida
    University of Miami
Sep 18, 2018

Serum suPAR in the CsA-treated FSGS Patients

Unknown status
  • FSGS
    • Guangzhou, Guangdong, China
      Nephrology Dept.,Guangdong General Hospital
    Apr 20, 2017

    FSGS Trial in Nanjing (FK506, Cyclophosphamide)

    Terminated
    • FSGS
    • Nanjing, Jiangsu, China
      Research Institute of Nephrology, Jinling Hospital, Nanjing Univ
    Mar 22, 2017